Evidence map›Paper›PMID 30511677›Full record

ArticleActa crystallographica. Section F, Structural biology communications2018

The structure of SDS22 provides insights into the mechanism of heterodimer formation with PP1.

Meng S Choy, Nicolas Bolik-Coulon, Tara L Archuleta, Wolfgang Peti, Rebecca Page

Abstract read
In one paragraph

Article in Acta crystallographica. Section F, Structural biology communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. SDS22 selectively recognizes and traps metal-deficient inactive PP1.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Meng S ChoyChemistry and Biochemistry, University of Arizona, 1041 East Lowell Drive, Biosciences West, Tucson, AZ 85281, USA.
Nicolas Bolik-CoulonChemistry and Biochemistry, University of Arizona, 1041 East Lowell Drive, Biosciences West, Tucson, AZ 85281, USA.ORCID 0000-0002-2759-5767
Tara L ArchuletaChemistry and Biochemistry, University of Arizona, 1041 East Lowell Drive, Biosciences West, Tucson, AZ 85281, USA.
Wolfgang PetiChemistry and Biochemistry, University of Arizona, 1041 East Lowell Drive, Biosciences West, Tucson, AZ 85281, USA.
Rebecca PageChemistry and Biochemistry, University of Arizona, 1041 East Lowell Drive, Biosciences West, Tucson, AZ 85281, USA.
University of Arizona · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
The Regulation of PP1 in the NucleusR01GM098482 · NIGMS · UNIVERSITY OF ARIZONA · PI PAGE, REBECCA · 2011 to 2019
$2.8M
Supplement for "Serine/Threonine Phosphatases in Neurological Diseases"R01NS091336 · NINDS · UNIVERSITY OF ARIZONA · PI PAGE, REBECCA, PETI, WOLFGANG · 2015 to 2019
$1.8M
Structural and Functional Analysis of Signaling Proteins in Dendritic SpinesR01NS056128 · NINDS · BROWN UNIVERSITY · PI PETI, WOLFGANG · 2007 to 2011
$1.7M
Protein Phosphatase 1 Holoenzyme Formation and Subunit ExchangeR01GM134683 · NIGMS · UNIVERSITY OF ARIZONA · PI PETI, WOLFGANG · 2019 to 2020
$564k
NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM098482NIGMS NIH HHS R01GM098482NIGMS NIH HHS R01 GM134683NINDS NIH HHS R01 NS056128NINDS NIH HHS R01NS056128NINDS NIH HHS R01 NS091336
6 · The paper itself

Abstract

Protein phosphatase 1 (PP1) dephosphorylates hundreds of key biological targets by associating with nearly 200 regulatory proteins to form highly specific holoenzymes. The vast majority of regulators are intrinsically disordered proteins (IDPs) and bind PP1 via short linear motifs within their intrinsically disordered regions. One of the most ancient PP1 regulators is SDS22, a protein that is conserved from yeast to mammals. Sequence analysis of SDS22 revealed that it is a leucine-rich repeat (LRR) protein, suggesting that SDS22, unlike nearly every other known PP1 regulator, is not an IDP but instead is fully structured. Here, the 2.9 Å resolution crystal structure of human SDS22 in space group P2

Indexed as

Amino Acid SequenceCell Cycle ProteinsNuclear ProteinsPhosphoprotein PhosphatasesProtein MultimerizationProtein Phosphatase 1Protein Structure, SecondaryProtein Structure, TertiarySaccharomyces cerevisiae ProteinsSchizosaccharomyces pombe ProteinsSequence HomologyCell Cycle ProteinsNuclear ProteinsPhosphoprotein PhosphatasesPPP1R7 protein, humanProtein Phosphatase 1Saccharomyces cerevisiae ProteinsSchizosaccharomyces pombe ProteinsSDS22 protein, S cerevisiaesds22 protein, S pombeLRR proteinPP1 regulatorprotein phosphatase 1SDS22

Identifiers

PMID30511677
PMCPMC6277963
OpenAlexW2902099658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.